Key Takeaways ANGO posted Q4 FY25 revenues of $80.2 million, up 12.9% and ahead of the consensus mark by 7.5%. Adjusted Q4 loss per share of 3 cents narrowed from 6 cents and beat the consensus mark of 13 cents. Gross margin fell 161 bps to 52.7% despite 9.4% growth in pro forma gross profit.AngioDynamics, Inc. (ANGO) reported an adjusted loss per share of 3 cents for fourth-quarter fiscal 2025, narrower than the year-ago quarter’s adjusted loss per share of 6 cents and the Zacks Consensus Estimate of a l ...